Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free SDCCQ Stock Alerts

SmileDirectClub (SDCCQ) Competitors

$0.0001 +0.00 (+∞)
As of 03:24 PM Eastern
Compare

SDCCQ vs. NUWE, SSKN, GMVDF, VRAYQ, and TTOO

Should you buy SmileDirectClub stock or one of its competitors? SmileDirectClub's main competitors and comparable companies include Nuwellis (NUWE), Strata Skin Sciences (SSKN), G Medical Innovations (GMVDF), ViewRay (VRAYQ), and T2 Biosystems (TTOO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does SmileDirectClub compare to Nuwellis?

Nuwellis (NASDAQ:NUWE) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

In the previous week, Nuwellis had 7 more articles in the media than SmileDirectClub. MarketBeat recorded 7 mentions for Nuwellis and 0 mentions for SmileDirectClub. SmileDirectClub's average media sentiment score of 0.00 beat Nuwellis' score of -0.28 indicating that SmileDirectClub is being referred to more favorably in the news media.

Company Overall Sentiment
Nuwellis Neutral
SmileDirectClub Neutral

Nuwellis has a beta of 0.31, indicating that its stock price is 69% less volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market.

3.1% of Nuwellis shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 1.6% of Nuwellis shares are owned by company insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Nuwellis has higher earnings, but lower revenue than SmileDirectClub. SmileDirectClub is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuwellis$8.27M0.29-$17.52M-$2.24 thousandN/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

SmileDirectClub has a net margin of 0.00% compared to Nuwellis' net margin of -123.38%. SmileDirectClub's return on equity of 0.00% beat Nuwellis' return on equity.

Company Net Margins Return on Equity Return on Assets
Nuwellis-123.38% -362.89% -158.38%
SmileDirectClub N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nuwellis
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
SmileDirectClub
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

SmileDirectClub beats Nuwellis on 9 of the 14 factors compared between the two stocks.

How does SmileDirectClub compare to Strata Skin Sciences?

Strata Skin Sciences (NASDAQ:SSKN) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

Strata Skin Sciences has higher earnings, but lower revenue than SmileDirectClub. SmileDirectClub is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

SmileDirectClub has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. SmileDirectClub's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Skin Sciences-35.64% -476.73% -33.49%
SmileDirectClub N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
SmileDirectClub
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by insiders. Comparatively, 64.7% of SmileDirectClub shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Strata Skin Sciences had 1 more articles in the media than SmileDirectClub. MarketBeat recorded 1 mentions for Strata Skin Sciences and 0 mentions for SmileDirectClub. Strata Skin Sciences' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
Strata Skin Sciences Neutral
SmileDirectClub Neutral

Strata Skin Sciences has a beta of 0.04, suggesting that its stock price is 96% less volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, suggesting that its stock price is 31% more volatile than the broader market.

Summary

SmileDirectClub beats Strata Skin Sciences on 8 of the 13 factors compared between the two stocks.

How does SmileDirectClub compare to G Medical Innovations?

G Medical Innovations (NASDAQ:GMVDF) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and institutional ownership.

G Medical Innovations has a beta of 29.41, meaning that its stock price is 2,841% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
SmileDirectClub N/A N/A N/A

G Medical Innovations has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.01-$24.63MN/AN/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
SmileDirectClub Neutral

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by company insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

G Medical Innovations beats SmileDirectClub on 4 of the 6 factors compared between the two stocks.

How does SmileDirectClub compare to ViewRay?

SmileDirectClub (NASDAQ:SDCCQ) and ViewRay (NASDAQ:VRAYQ) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
ViewRay Neutral

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
ViewRay N/A N/A N/A

SmileDirectClub has a beta of 1.31, indicating that its share price is 31% more volatile than the broader market. Comparatively, ViewRay has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

SmileDirectClub has higher revenue and earnings than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A
ViewRay$102.21M0.00-$107.33MN/AN/A

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 15.5% of ViewRay shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 2.5% of ViewRay shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

SmileDirectClub beats ViewRay on 4 of the 6 factors compared between the two stocks.

How does SmileDirectClub compare to T2 Biosystems?

T2 Biosystems (NASDAQ:TTOO) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

T2 Biosystems has higher earnings, but lower revenue than SmileDirectClub. SmileDirectClub is trading at a lower price-to-earnings ratio than T2 Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

T2 Biosystems has a beta of 7.75, meaning that its stock price is 675% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market.

23.2% of T2 Biosystems shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 0.0% of T2 Biosystems shares are owned by insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

SmileDirectClub has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
T2 Biosystems-563.16% N/A -174.06%
SmileDirectClub N/A N/A N/A

In the previous week, T2 Biosystems' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
T2 Biosystems Neutral
SmileDirectClub Neutral

Summary

T2 Biosystems and SmileDirectClub tied by winning 5 of the 10 factors compared between the two stocks.

Get SmileDirectClub News Delivered to You Automatically

Sign up to receive the latest news and ratings for SDCCQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDCCQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SDCCQ vs. The Competition

Export
MetricSmileDirectClubHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$40K$5.95B$7.06B$13.10B
Dividend YieldN/A1.76%2.57%10.45%
P/E Ratio0.0026.22269.0625.28
Price / Sales0.0063.09592.5787.62
Price / CashN/A33.9270.4850.90
Price / BookN/A6.1012.916.24
Net Income-$86.40M$148.67M$3.45B$347.60M

SmileDirectClub Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SDCCQ
SmileDirectClub
N/A$0.00
+∞		N/AN/A$40K$470.74MN/A2,700
NUWE
Nuwellis
0.2274 of 5 stars		$1.61
-7.5%		N/A-99.3%$130K$8.27MN/A70
SSKN
Strata Skin Sciences
0.1134 of 5 stars		$0.01
flat		N/A-100.0%$32K$30.98MN/A120
GMVDF
G Medical Innovations
N/AN/AN/AN/A$26K$4.42MN/A72
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21MN/A300

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SDCCQ) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
AI insiders stockpile guns, gold & gas masks
Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift...
TradeSmith | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel